Among these genes, EGFR is recognized as a driving receptor tyrosine kinase (RTK) in glioblastoma and induces multiple oncogenic signaling, which accounts for approximately 60% of glioblastoma cases [14]. This evidence concerns the gene EGFR and glioblastoma.